Ampa
Overview
Ampa is a neurotechnology company that makes Ampa One, a portable, lightweight, camera-guided, FDA-cleared TMS device. Ampa One is available via subscription with no upfront cost or per-treatment fee. Ampa One is pioneering One-Day TMS treatment and is designed to make an established therapy practical for practices that previously could not offer it. Founded by researchers who helped pioneer modern TMS protocols, Ampa's mission is to enable one billion remissions from mental and neurological disorders.
More in Neurotechnology
Latest industry news
Dual-Branch Deep Learning Network Sets New Bar for Motor Imagery BCI Decoding
2026-11-07 · Research
Nurosym Launches Wearable VNS Device as Neuromodulation Interest Reaches New Heights
2026-11-06 · Product
Brain-Computer Interface Project Aims to Build a Google Map of the Human Brain
2026-11-05 · Research
Migraine Device Delivers Drug-Free Relief for Veterans in New Clinical Study
2026-11-04 · Research
Company details
Category
🏢 Neurotechnology
Funding
Private
Listed
2026-07-10
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →